Saturday, September 23, 2023
Saturday, September 23, 2023

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

Effective June 1, Wenlei Yang will be named Chief Diversity, Equity and Inclusion Officer for Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling.

Dei Efforts Concerning Other Pillars, Including Age, Race, Sexual Orientation, Gender Identity, Socioeconomic Status, Ethnicity, (Dis)Ability, Religion, Opinions And Political Stance, Are All Equally Important In Olympus.

In this newly established role, Wenlei Yang will drive, oversee and implement initiatives related to Olympus’ new Diversity, Equity and Inclusion (DEI) directions set as part of the company’s global ESG strategy announced on May 12, 2023. The company will deepen measures to fully realize the DEI principles in all facilities worldwide to foster a healthy organizational culture.

Wenlei Yang joined Olympus in 1992 and held various roles during the following 18 years, mainly in global sales and marketing positions across China, Hong Kong and Japan. In 2010, she was assigned Head of Sales & Marketing Division and General Manager of the Imaging Business and General Manager of Olympus China. Wenlei was then appointed Regional Representative Officer, China in 2019. In 2023, she was appointed Regional Representative Officer, Japan. Moving forward, Wenlei will continue to represent Japan as the Regional Representative Officer and will also lead initiatives related to Olympus’ global DEI strategy.

“Both employees and society hold expectations of DEI that are constantly evolving, and as a leading global MedTech company, we must remain informed of global trends and implement appropriate solutions for Olympus to meet the expectations of our stakeholders,” said Shigeto Ohtsuki, Olympus Chief Human Resources Officer. “The creation of this new role will ensure a strong global governance structure for our DEI program. Together with Wenlei’s multilingual skills and extensive global management experience, her background exemplifies the benefits and goals of being committed to DEI principles. I am confident that Wenlei’s seasoned leadership will propel our organization toward our DEI goals.”

Olympus continuously works to build an inclusive culture and equitable systems, where everyone, including those within the communities it serves, is accepted for who they are, with equal access to opportunities.

The company has formulated a vision and developed a phased plan to advance all aspects of DEI in Olympus. After the foundation is set in the initial phase, company processes and systems will be reviewed through a DEI lens, making DEI part of its daily operations to further contribute to its external partners and the communities Olympus serves.

Four key themes are prioritized at the global level[1] under the DEI strategy

1. Gender and Life Priority: Further support for women employees and all caretakers[2] that may have time constraints due to personal life events.
2. Nationality and Culture: Increase diversity and ensure equitable access to opportunities regardless of nationality, culture or language skills.
3. Career and Experience: Enhance employee professional experience and broaden the perspective of team and organizational coverage.
4. Inclusive Environment: Ensure an environment where everyone can speak up freely and collaborate effectively.

To address the four themes, on top of ongoing initiatives[3], concrete new initiatives will continue to be introduced to global employees.

KPIs and targets to accelerate DEI initiatives

1. Achieve 30% representation of women in management roles globally and 13% at Olympus Corporation (Japan) by the fiscal year ending March 31, 2028.
2. Achieve 100% of eligible men in Japan taking parental leave by FY2026.
3. Increase nationality and cultural diversity in the organization and increase employee engagement survey scores.

[1] DEI efforts concerning other pillars, including age, race, sexual orientation, gender identity, socioeconomic status, ethnicity, (dis)ability, religion, opinions and political stance, are all equally important in Olympus. Further increases in diversity and ensuring equity in each pillar will be driven in each region, taking regional features into account.
[2] Caregivers are people who need to work and care for their children, parents, or other loved ones.
[3] Includes global DEI training for managers, enhanced work-life balance support for all genders, increased opportunities to apply for global roles, language learning opportunities, and a pilot Peer Learning Program.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

By using this website you agree to accept Medical Device News Magazine Privacy Policy